Publications by authors named "Stepanyan N"

The ability of the SARS-CoV-2 virus to cause DNA damage in infected humans requires its study as a potential indicator of COVID-19 progression. DNA damage was studied in leukocytes of 65 COVID-19 patients stratified by sex, age, and disease severity in relation to demographic, clinical, and laboratory parameters. In a combined group of COVID-19 patients, DNA damage was shown to be elevated compared to controls (12.

View Article and Find Full Text PDF

The development of devices for the in situ resource utilization (ISRU) of lunar surface powder (regolith) by means of microwaves needs regolith simulants with electromagnetic properties similar to the lunar regolith. This document deals with the measurement of complex permittivity and dielectric loss tangent of the aforementioned simulants at ambient temperature from 400 MHz to 20 GHz, performing measurements using two lunar dust simulants, EAC-1A and JSC-2A, resulting, on the one hand, in permittivity values of ε'=-0.0432f+4.

View Article and Find Full Text PDF

COVID-19 is a real challenge for the protective immunity. Some people do not respond to vaccination by acquiring an appropriate immunological memory. The risk groups for this particular infection such as the elderly and people with compromised immunity (cancer patients, pregnant women, etc.

View Article and Find Full Text PDF

Mesenchymal stem cells (MSC) are characterized by tolerogenic potential and therefore, are used in the treatment of autoimmune diseases such as graft-versus-host disease (GVHD) reactions after allogeneic hematopoietic cell transplantation to improve the transplant functions, as well as for the therapy and prevention of cytokine storm in COVID-19 patients and some other conditions. However, MSC can exhibit proinflammatory activity, which causes risks for their clinical use. We studied the cytokine profile of bone marrow MSC culture and demonstrate intensive production of IL-6, IL-8, and chemokine MCP-1, which participate in the pathogenesis of cytokine storm and GVHD.

View Article and Find Full Text PDF

The potential of mesenchymal multipotent (stem) cells (MSC) to modify immune reactions and mediate hematopoiesis boosted great interest for their use in allogeneic hemopoietic stem cell transplantation. Because of MSC production of a wide range of cytokines and growth factors, these cells are included in the therapy of graft-versus-host disease (GVHD). A number of clinical studies have demonstrated safety and efficacy of MSC-based therapy in acute GVHD.

View Article and Find Full Text PDF